Clinical Trials Directory

Trials / Completed

CompletedNCT04841707

Total-Body Parametric 18F-FDG PET of COVID-19

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
13 (actual)
Sponsor
University of California, Davis · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective is to measure the change between COVID-19 patients and normal subjects; the secondary objective is to measure the change in COVID-19 patients between baseline and 4-month follow up.

Conditions

Interventions

TypeNameDescription
DEVICEuEXPLORER/mCTEach participant will undergo two 18F-FDG PET/CT scans, one at baseline and one at 4- month (+/- 2 weeks) follow-up.

Timeline

Start date
2021-05-10
Primary completion
2022-07-06
Completion
2022-07-06
First posted
2021-04-12
Last updated
2026-03-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04841707. Inclusion in this directory is not an endorsement.